VRHID (Veri Medtech Holdings) YoY EPS Growth: 0.00% (As of Dec. 2021)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VRHID Veri Medtech Holdings Inc VRHID
35 GF Score
Price $6.00
View Full Analysis

What is Veri Medtech Holdings YoY EPS Growth?

Veri Medtech Holdings VRHID +2.28% 35 YoY EPS Growth is 0.00% as of Dec. 2021. GuruFocus rates VRHID with a GF Score™ of 35/100.

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Veri Medtech Holdings's YoY EPS Growth for the quarter that ended in Dec. 2021 was 0.00%.

Veri Medtech Holdings's Earnings per Share (Diluted) for the six months ended in Dec. 2021 was $0.00.

Veri Medtech Holdings YoY EPS Growth Historical Data

* Premium members only.

The historical data trend for Veri Medtech Holdings's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veri Medtech Holdings YoY EPS Growth Chart

Veri Medtech Holdings Annual Data
Trend Dec21
YoY EPS Growth
0.00

Veri Medtech Holdings Semi-Annual Data
Dec21
YoY EPS Growth 0.00
VRHID
35GF Score
Veri Medtech Holdings Inc VRHID
YoY EPS Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Veri Medtech Holdings YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Veri Medtech Holdings's YoY EPS Growth for the fiscal year that ended in Dec. 2021 is calculated as:

YoY EPS Growth (A: Dec. 2021 )
=(Earnings per Share (Diluted) (A: Dec. 2021 )-Earnings per Share (Diluted) (A: . 20 ))/ | Earnings per Share (Diluted) (A: . 20 ) |
=(0-)/ | |
=N/A %

Veri Medtech Holdings's YoY EPS Growth for the quarter that ended in Dec. 2021 is calculated as:

YoY EPS Growth (Q: Dec. 2021 )
=(Earnings per Share (Diluted) (Q: Dec. 2021 )-Earnings per Share (Diluted) (Q: . 20 )) / | Earnings per Share (Diluted) (Q: . 20 ) |
=(0-)/ | |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EPS Growth →
What does a YoY EPS Growth of 0.00% mean?
Veri Medtech Holdings (VRHID) has a YoY EPS Growth of 0.00% as of Dec. 2021. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Veri Medtech Holdings and its competitors.
Is Veri Medtech Holdings' YoY EPS Growth too high?
Veri Medtech Holdings' current YoY EPS Growth is 0.00%. Overall, Veri Medtech Holdings has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Veri Medtech Holdings' YoY EPS Growth compare to MMVVF and BLMZ?
Veri Medtech Holdings' YoY EPS Growth of 0.00% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EPS Growth for a Healthcare Providers & Services company?
A good YoY EPS Growth depends on the Healthcare Providers & Services industry context. However, YoY EPS Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EPS Growth mean?
A high YoY EPS Growth can signal that a stock is expensive relative to its fundamentals. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Veri Medtech Holdings and its competitors. Veri Medtech Holdings's current YoY EPS Growth is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veri Medtech Holdings stock overvalued right now?
Veri Medtech Holdings (VRHID) has a current YoY EPS Growth of 0.00%. The current YoY EPS Growth is 0.00%. Veri Medtech Holdings' overall GF Score™ is 35/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EPS Growth calculated?
YoY EPS Growth is calculated from a company's financial statements. For Veri Medtech Holdings (VRHID), the current YoY EPS Growth is 0.00% as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Veri Medtech Holdings Business Description

Address 1660 International Drive, Suite 600, McClean, VA, USA, 22101
Veri Medtech Holdings Inc is a healthcare technology company that offers alternative medicine, personalized diagnostics, and wellness medication on demand. The company leverages telehealth infrastructure, diagnostic intelligence, and scalable digital systems to meet the growing demand for accessible, stigma-free healthcare. Strategically positioned for growth, Veri MedTech actively explores acquisitions that complement its core capabilities and enhance patient engagement across emerging sectors of alternative medicine, longevity, and wellness science. With an integration and operational efficiency track record, the company drives accelerated revenue through the continuous generation of high-value patient databases and recurring service models.
35GF Score

Get the complete analysis for VRHID

YoY EPS Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.00
Price